These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31293503)

  • 21. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
    World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
    Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
    J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.
    Kamimura T; Okazaki S; Morimoto T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Yoshimoto T; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Maruyama H; Koizumi A; Ihara M
    Stroke; 2019 Jun; 50(6):1561-1563. PubMed ID: 31060437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease.
    Yu X; Ge P; Zhai Y; Wang R; Zhang Y; Zhang D
    Front Neurol; 2022; 13():891622. PubMed ID: 35959391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.
    Ye F; Li J; Wang T; Lan K; Li H; Yin H; Guo T; Zhang X; Yang T; Liang J; Wu X; Li Q; Sheng W
    Front Neurol; 2020; 11():608000. PubMed ID: 33519687
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease.
    Kang K; Lu J; Ju Y; Ji R; Wang D; Shen Y; Yu L; Gao B; Zhang D; Zhao X
    Front Neurol; 2020; 11():382. PubMed ID: 32457693
    [No Abstract]   [Full Text] [Related]  

  • 35. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease: Longitudinal and Cross-Sectional Study.
    Wang XP; Zou ZX; Bao XY; Wang QN; Ren B; Yu D; Zhang Q; Liu JQ; Hao FB; Gao G; Guo QB; Fu HG; Li JJ; Wang MJ; Liu SM; Duan L
    Heliyon; 2024 Feb; 10(4):e26108. PubMed ID: 38404780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Oct; 439(4):419-26. PubMed ID: 23994138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in Angiographic Characteristics Between Hemorrhagic And Nonhemorrhagic Hemispheres Associated with Hemorrhage Risk of Moyamoya Disease in Adults: A Self-Controlled Study.
    Liu P; Liu AH; Han C; Chen C; Lv XL; Li DS; Ge HJ; Jin HW; Li YX; Duan L
    World Neurosurg; 2016 Nov; 95():348-356. PubMed ID: 27554309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Features, Surgical Treatment, and Long-Term Outcome in Children with Hemorrhagic Moyamoya Disease.
    Ge P; Zhang Q; Ye X; Wang S; Zhang D; Zhao J
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1517-1523. PubMed ID: 29567119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.